FLT3 Inhibitor AML Medication Generic

Quizartinib, an FLT3 inhibitor, is used for treating AML with FLT3-ITD mutations, especially in cases that have relapsed or don’t respond to standard treatment. What it does is it blocks the FLT3 signaling, which is what causes the AML cells to multiply. The usual dosage is 53 mg a day, starting with a gradual increase.

There are these tablets in two sizes: 17.7 mg and 26.5 mg. Each bottle has 28 tablets, making it easy to dose and adjust for patients’ needs.